Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

Novartis Investigative Site, Jesus Maria

Novartis Investigative Site, San Isidro

Novartis Investigative Site, Saida

Novartis Investigative Site, Caracas

Novartis Investigative Site, Caracas

Novartis Investigative Site, Vienna

Novartis Investigative Site, Budapest

Novartis Investigative Site, Vienna

Novartis Investigative Site, Clayton

Novartis Investigative Site, Geelong

Novartis Investigative Site, Linz

Novartis Investigative Site, Greenslopes

Novartis Investigative Site, Douglas

Novartis Investigative Site, Innsbruck

Novartis Investigative Site, Beirut

Novartis Investigative Site, Bellinzona

Novartis Investigative Site, Kaposvár

Novartis Investigative Site, Pécs

Novartis Investigative Site, Zurich

Novartis Investigative Site, Bangkok

Novartis Investigative Site, Bangkok

Novartis Investigative Site, Gyeonggi-do

Novartis Investigative Site, Bangkok

Novartis Investigative Site, Cadiz

Novartis Investigative Site, Riyadh

Novartis Investigative Site, Athens

Novartis Investigative Site, Cairo

Novartis Investigative Site, Cairo

University of Pittsburgh Medical Center SC-3, Pittsburgh

Novartis Investigative Site, Dammam

Novartis Investigative Site, Bad Saarow

Novartis Investigative Site, Genova

Novartis Investigative Site, Donostia / San Sebastian

Novartis Investigative Site, Rozzano

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Milan

Novartis Investigative Site, Jeddah

Blue Ridge Research Center at Roanoke Neurological Center SC, Roanoke

Wake Forest University Baptist Medical Center Dept. of WFUHS, Winston-Salem

Novartis Investigative Site, Madrid

Levine Cancer Institute Oncology, Charlotte

Novartis Investigative Site, Majadahonda

Novartis Investigative Site, Pozuelo de Alarcón

Novartis Investigative Site, Piacenza

Novartis Investigative Site, Brest

Medical University of South Carolina -Hollings Cancer Center MUSC/HCC (2), Charleston

Cancer Centers of the Carolinas Cancer Centers of Carolinas (3, Greenville

Novartis Investigative Site, Venezia

University Cancer & Blood Center, LLC, Athens

Novartis Investigative Site, Pamplona

Columbus Regional, Columbus

University Cancer Institute, Boynton Beach

Novartis Investigative Site, Pessac

Novartis Investigative Site, Istanbul

Novartis Investigative Site, Al Mansurah

Novartis Investigative Site, Talas / Kayseri

University of Tennessee Cancer Institute SC-2, Memphis

The West Clinic, Memphis

Novartis Investigative Site, Santander

Novartis Investigative Site, Seville

Novartis Investigative Site, Modena

Novartis Investigative Site, Reggio Emilia

Novartis Investigative Site, Saint-Priest-en-Jarez

Novartis Investigative Site, Valencia

Indiana University Hospital IU Cancer Center, Indianapolis

Novartis Investigative Site, Petah Tikva

Novartis Investigative Site, Florence

Novartis Investigative Site, Cologne

Novartis Investigative Site, Aachen

Novartis Investigative Site, Siena

Waukesha Memorial Hospital Cancer Center Dept.ofWaukeshaMemorialHosp., Waukesha

Dean Health System, Madison

Mayo Clinic - Rochester Dept. of MayoClinic-Rochester, Rochester

Novartis Investigative Site, Pisa

Rush University Medical Center Div. of Hematology & Oncology, Chicago

Washington University School of Medicine Div. of Medical Oncology, St Louis

Novartis Investigative Site, Monterrey

Novartis Investigative Site, Tel Aviv

Novartis Investigative Site, Pescara

Tulane University Health Sciences Center Office of Clinical Research, New Orleans

Novartis Investigative Site, San Giovanni Rotondo

Novartis Investigative Site, Brindisi

Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville

Novartis Investigative Site, Lecce

The Center for Cancer and Blood Disorders Dept. of The Ctr for C & BD, Fort Worth

Texas A&M HealthSciencesCtr-Scott & White Memorial Hospital CenterForCancerPrevention&Care, Temple

Baylor College of Medicine Dept.of Baylor College of Med., Houston

South Texas Oncology and Hematology, PA South Texas Oncology (2), San Antonio

Novartis Investigative Site, Freiburg im Breisgau

Novartis Investigative Site, Amiens Cedex1

University of Colorado Health, Colorado Springs

Novartis Investigative Site, München

Novartis Investigative Site, Potenza

Ironwood Cancer and Research Centers SC, Chandler

Novartis Investigative Site, La Roche-sur-Yon

Novartis Investigative Site, Limoges

Novartis Investigative Site, Reggio Calabria

USC/Kenneth Norris Comprehensive Cancer Center Dept.ofNorrisMedicalCenter(4), Los Angeles

Novartis Investigative Site, Songkhla

Novartis Investigative Site, Palermo

Novartis Investigative Site, Jerusalem

Novartis Investigative Site, Catania

Novartis Investigative Site, Bamberg

Novartis Investigative Site, Beijing

Novartis Investigative Site, Beijing

Novartis Investigative Site, Moscow

Novartis Investigative Site, Singapore

Novartis Investigative Site, Moscow

Novartis Investigative Site, Moscow

Novartis Investigative Site, Beirut

Novartis Investigative Site, Beirut

Novartis Investigative Site, Singapore

Novartis Investigative Site, Singapore

Novartis Investigative Site, Petrozavodsk

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Shanghai

Novartis Investigative Site, Hangzhou

Novartis Investigative Site, Guangzhou

Novartis Investigative Site, Nizhny Novgorod

Novartis Investigative Site, Chengdu

Novartis Investigative Site, Haifa

Novartis Investigative Site, Ramat Gan

University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (3), La Jolla

Denver Health & Hospital Authority CACZ885M2301, Denver

Rocky Mountain Cancer Centers RMCC, Greenwood Village

Novartis Investigative Site, Bogotá

Novartis Investigative Site, Bucaramanga

Novartis Investigative Site, Medellín

Novartis Investigative Site, Alexandria

Novartis Investigative Site, Cairo

Novartis Investigative Site, Hong Kong

Novartis Investigative Site, Grafton

Novartis Investigative Site, Wellington

Lahey Clinic Dept of Lahey Clinic (3), Burlington

Dartmouth Hitchcock Medical Center Dartmouth, Lebanon

University of Texas/MD Anderson Cancer Center Dept of MD Anderson (18), Houston

University of Vermont Office of Clinical Trials Res., Burlington

University of Virginia Health Systems SC-2, Charlottesville

Novartis Investigative Site, La Plata

Novartis Investigative Site, Buenos Aires

Novartis Investigative Site, Córdoba

Novartis Investigative Site, Leoben

Novartis Investigative Site, Curitiba

Novartis Investigative Site, Porto Alegre

Novartis Investigative Site, Campinas

Novartis Investigative Site, São Paulo

Novartis Investigative Site, São Paulo

Novartis Investigative Site, Brampton

Novartis Investigative Site, Cambridge

Novartis Investigative Site, Mississauga

Novartis Investigative Site, Ottawa

Novartis Investigative Site, Toronto

Novartis Investigative Site, Toronto

Novartis Investigative Site, Greenfield Park

Novartis Investigative Site, Montreal

Novartis Investigative Site, Montreal

Novartis Investigative Site, Québec

Novartis Investigative Site, Brno - Bohunice

Novartis Investigative Site, Hradec Králové

Novartis Investigative Site, Olomouc

Novartis Investigative Site, Prague

Novartis Investigative Site, Dresden

Novartis Investigative Site, Heraklion Crete

Novartis Investigative Site, Athens

Novartis Investigative Site, Ioannina

Novartis Investigative Site, Győr

Novartis Investigative Site, Szeged

Novartis Investigative Site, Nagoya

Novartis Investigative Site, Kashiwa

Novartis Investigative Site, Matsuyama

Novartis Investigative Site, Kure

Novartis Investigative Site, Kanazawa

Novartis Investigative Site, Shinjuku-ku

Novartis Investigative Site, Kyoto

Novartis Investigative Site, Sendai

Novartis Investigative Site, Osaka

Novartis Investigative Site, Suita

Novartis Investigative Site, Sunto-gun

Novartis Investigative Site, Chuo-ku

Novartis Investigative Site, Koto

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Beirut

Novartis Investigative Site, Mexico City

Novartis Investigative Site, Oslo

Novartis Investigative Site, Lublin

Novartis Investigative Site, Bydgoszcz

Novartis Investigative Site, Lodz

Novartis Investigative Site, Warsaw

Novartis Investigative Site, Bratislava

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Sabadell

Novartis Investigative Site, Badalona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Ankara

Novartis Investigative Site, Ankara

Novartis Investigative Site, Antalya